[ad_1] NANJING, China, Sept. 14, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the […]
[ad_1] NANJING, China, Sept. 14, 2024 /PRNewswire/ — On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the […]
[ad_1] NANJING, Chine, le 2 sept. 2024 /PRNewswire/ — Le 2 septembre 2024, Simcere Zaiming, une société d’oncologie innovante du groupe Simcere Pharmaceutical (2096.HK), a annoncé un accord de collaboration avec Shenzhen TargetRx Inc. Ce partenariat porte […]
[ad_1] NANJING, China, 2 september 2024 /PRNewswire/ — Op 2 september 2024 kondigde Simcere Zaiming, een innovatief oncologiebedrijf onder Simcere Pharmaceutical Group (2096.HK), een samenwerkingsovereenkomst aan met Shenzhen TargetRx Inc. De samenwerking richt zich op de […]
[ad_1] NANJING, China, Sept. 2, 2024 /PRNewswire/ — On September 02, 2024, Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group (2096.HK), announced a collaboration agreement with Shenzhen TargetRx Inc. The partnership focuses on the […]
